| Nikhil Lalwani | President and Chief Executive Officer | FY2025 | |
| Christopher K. Mutz | Senior Vice President, Head of Rare Disease | FY2025 | |
| Stephen P. Carey | Senior Vice President, Finance and Chief Financial Officer | FY2025 | |
| Meredith W. Cook | Senior Vice President, General Counsel and Corporate Secretary | FY2025 | |
| Ori Gutwerg | Senior Vice President, Generics | FY2025 |
5 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.